YD0743

· Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YD0743, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS [Phase 2]